Access cutting-edge non small cell lung cancer treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Access non small cell lung cancer specialists in Sacramento at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non small cell lung cancer treatment provided free
The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who have disease progressed on anti-PD-1/PD-L1 antibody based therapy. The study will test whether gotistobart, in comparison with chemotherapy agent docetaxel, could prolong the life for NSCLC patients. Patients will be randomized to be treated with either gotistobart or docetaxel, IV infusion, once eve
Sponsor: OncoC4, Inc.
Check if you qualify for this non small cell lung cancer clinical trial in Sacramento, CA
If you're searching for non small cell lung cancer treatment options in Sacramento, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.